Symbols

HAE

Haemonetics·NYSE

--(--)

HAE fundamentals

HAE Q4 2026 Earnings Preview

Haemonetics (HAE) expects to report earnings on May 7, 2026, with estimated revenue of 337.04M (YoY +1.95%), and EPS at 1.2718 (YoY +2.56%).

Revenue estimate / YoY

337.04M

+1.95%

EPS estimate / YoY

1.2718

+2.56%

Report date

May 7, 2026

Earnings Call

8:00 AM on May 7, 2026

Meeting link.

Earnings

EPS

Revenue

Revenue & Expenses

HAE has released its 2026 Q3 earnings report, with revenue of 338.97M, reflecting a YoY change of -2.75%, and net profit of 44.74M, showing a YoY change of 19.33%. The Sankey diagram below clearly presents HAE's revenue sources and cost distribution.

Key Indicators

Haemonetics (HAE) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Haemonetics (HAE)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Haemonetics (HAE)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Haemonetics (HAE)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown